메뉴 건너뛰기




Volumn 42, Issue 6, 2001, Pages 1379-1383

Immunophenotype changes and loss of CD52 expression in two patients with relapsed T-cell prolymphocytic leukaemia

Author keywords

CAMPATH 1H; Chemotherapy; Phenotypic switch; T cell prolymphocytic leukaemia

Indexed keywords

ALEMTUZUMAB; BLEOMYCIN; CD19 ANTIGEN; CD2 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD52 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; CLADRIBINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DANAZOL; DOXORUBICIN; ERYTHROPOIETIN; ETOPOSIDE; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; METHOTREXATE; MITOMYCIN; PENTOSTATIN; PREDNISONE; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; VINCRISTINE SULFATE;

EID: 0035691895     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190127515     Document Type: Article
Times cited : (21)

References (10)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.